Expect to Hear About Renal Protection With Newer Diabetes Meds
September 2018
You'll hear buzz about using SGLT2 inhibitors (Jardiance, etc) or GLP-1 agonists (Victoza, etc) for renal protection in type 2 diabetes.
We know ACE inhibitors or ARBs slow progression of nephropathy in diabetes patients with hypertension and albuminuria.
Now data suggest Jardiance (empagliflozin) or Invokana (canagliflozin) may provide some renal protection...probably by lowering intraglomerular pressure.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote